Illumina is a diagnostics & research business based in the US. Illumina shares (ILMN) are listed on the NASDAQ and all prices are listed in US Dollars.
Its last market close was $90.26 , which is an increase of 3.83% over the previous week. Illumina employs 8,970 staff and has a trailing 12-month revenue of around $4.3 billion.Our top picks for where to buy Illumina stock
How to buy Illumina stock
- Choose a stock trading platform. Compare investment platforms.
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – ILMN. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Illumina stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Note: The dollar amounts in the table below are in Canadian dollars.
Finder Score for stock trading platforms
To make comparing even easier we came up with the Finder Score. Trading costs, account fees and features across 10+ stock trading platforms and apps are all weighted and scaled to produce a score out of 10. The higher the score the better the platform - simple.
Illumina stock price (NASDAQ: ILMN)
Use our graph to track the performance of ILMN stocks over time.Illumina stocks at a glance
Latest market close | $90.26 |
---|---|
52-week range | $68.70 - $156.66 |
50-day moving average | $79.03 |
200-day moving average | $114.11 |
Wall St. target price | $108.48 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-6.08 |
Is it a good time to buy Illumina stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Illumina stock undervalued or overvalued?
Valuing Illumina stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Illumina's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Illumina's PEG ratio
Illumina's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.622. A low ratio can be interpreted as meaning the stocks offer better value, while a higher ratio can be interpreted as meaning the stocks offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Illumina's future profitability. By accounting for growth, it could also help you if you're comparing the stock prices of multiple high-growth companies.
Illumina's EBITDA
Illumina's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $958 million.
The EBITDA is a measure of a Illumina's overall financial performance and is widely used to measure a its profitability.
Illumina financials
Revenue TTM | $4.3 billion |
---|---|
Operating margin TTM | 17.67% |
Gross profit TTM | $3 billion |
Return on assets TTM | 4.96% |
Return on equity TTM | -23.85% |
Profit margin | -22.27% |
Book value | $14.89 |
Market Capitalization | $14 billion |
TTM: trailing 12 months
Illumina stock dividends
We're not expecting Illumina to pay a dividend over the next 12 months.
Have Illumina's stocks ever split?
Illumina's stocks were split on a 1028:1000 basis on 24 June 2024 . So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1028 shares. This wouldn't directly have changed the overall worth of your Illumina stocks – just the quantity. However, indirectly, the new 2.7% lower stock price could have impacted the market appetite for Illumina stocks, which in turn could have impacted Illumina's stock price.
Illumina stock price volatility
Over the last 12 months, Illumina's stocks have ranged in value from as little as $68.7 up to $156.66. A popular way to gauge a stock's volatility is its "beta."
Beta is a measure of a stocks volatility in relation to the market. The market (NASDAQ average) beta is 1, while Illumina's is 1.326. This would suggest that Illumina's stocks are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Illumina overview
Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc.
Frequently asked questions
What percentage of Illumina is owned by insiders or institutions?Currently 0.223% of Illumina stocks are held by insiders and 107.114% by institutions. How many people work for Illumina?
Latest data suggests 8,970 work at Illumina. When does the fiscal year end for Illumina?
Illumina's fiscal year ends in December. Where is Illumina based?
Illumina's address is: 5200 Illumina Way, San Diego, CA, United States, 92122 What is Illumina's ISIN number?
Illumina's international securities identification number is: US4523271090 What is Illumina's CUSIP number?
Illumina's Committee on Uniform Securities Identification Procedures number is: 452327109
More on investing

What are the best stocks for beginners with little money to invest?
Want to dive into investing but don’t have much to spend? Take a look at these types of stocks.
Read more…
Meme stocks: What they are and examples of popular stocks
Meme stocks can produce large gains in short periods, but the stocks are volatile.
Read more…
How do ETFs work?
Your guide to how ETFs work and whether this type of investment is right for you.
Read more…More guides on Finder
-
Best day trading platforms in Canada
Compare six brokerage platforms to find the best platform for day trading in Canada.
-
Best renewable energy stocks
These are the best renewable energy stocks to buy now in Canada.
-
Graphene stocks
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
-
Best stocks to buy right now in Canada
Finder’s unique algorithm found the 20 best TSX stocks to buy right now.
-
10 best trading platforms and apps in Canada for 2025
Whether you’re a new or experienced investor, these are the best stock trading platforms and apps in Canada.
-
How to buy US stocks in Canada
Buying US stocks in Canada is easier than you think. Find out how to buy US stocks in 4 simple steps.
-
How to buy international stocks in Canada
Find out how to buy international stocks in Canada in three easy steps.
-
How to invest in the S&P 500 in Canada
Find out how to invest in the S&P 500 in Canada—one of the world’s most popular stock indices—to diversify your portfolio.
-
Qtrade review
Qtrade offers free trades for 100+ ETFs and discounts for active and young investors. But the platform has some drawbacks.
-
Questrade review
Questrade is a leader among Canadian discount brokerages, but is it right for you? Compare fees, features and alternatives here.